85 results on '"Catala, I."'
Search Results
2. Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
- Author
-
Pros, E., Saigi, M., Alameda, D., Gomez-Mariano, G., Martinez-Delgado, B., Alburquerque-Bejar, J.J., Carretero, J., Tonda, R., Esteve-Codina, A., Catala, I., Palmero, R., Jove, M., Lazaro, C., Patiño-Garcia, A., Gil-Bazo, I., Verdura, S., Teulé, A., Torres-Lanzas, J., Sidransky, D., Reguart, N., Pio, R., Juan-Vidal, O., Nadal, E., Felip, E., Montuenga, L.M., and Sanchez-Cespedes, M.
- Published
- 2020
- Full Text
- View/download PDF
3. Voluntad política para un tiempo de reformas: Presupuestos previos para abordar una reforma constitucional
- Author
-
Alexandre H. Catala i Bas
- Subjects
Reforma constitucional ,Debate ,Racionalidad ,Consenso ,Lealtad ,Proceso constituyente ,Law in general. Comparative and uniform law. Jurisprudence ,K1-7720 ,Comparative law. International uniform law ,K520-5582 - Abstract
La gran mayoría de españoles desean que la Constitución de 1978 se reforme. Para ello es necesario o, al menos, conveniente que se den una serie de presupuestos previos: que se debata de forma racional sobre ideas, que se minimice al máximo la crispación, que se busque el consenso y que se debata desde la lealtad. El autor coincide con el sentir de gran parte de la doctrina en el sentido de que más que hablar de una reforma hay que hablar de reformas que deberían acometerse gradualmente. También en que no se trata de abrir un nuevo proceso constituyente. Advierte que una anomalía, el llamado proceso independentista catalán, no puede ser el detonante ni condicionar las reformas que se vayan a acometer. Este trabajo está realizado teniendo muy presente la actualidad política por la que se atraviesa. Por ello, junto a citas doctrinales hay constantes referencias a declaraciones de políticos en entrevistas o sesiones parlamentarias, a artículos periodísticos o a barómetros del CIS. Recibido: 30.05.2019 Aceptado: 16.12.2019 Publicación en línea: 31.12.2019
- Published
- 2019
- Full Text
- View/download PDF
4. Aberrant gene methylation and bronchial dysplasia in high risk lung cancer patients
- Author
-
Rosell, A., Rodríguez, N., Monsó, E., Taron, M., Millares, L., Ramírez, J.L., López-Lisbona, R., Cubero, N., Andreo, F., Sanz, J., Llatjós, M., Llatjós, R., Fernández-Figueras, M.T., Mate, J.L., Català, I., Setó, L., Roset, M., Díez-Ferrer, M., and Dorca, J.
- Published
- 2016
- Full Text
- View/download PDF
5. La confrontación de derechos en los escraches // THE CONFRONTATION BETWEEN RIGHTS AND THE PRACTICE OF«ESCRACHES»
- Author
-
Alexandre H. Catala i Bas
- Subjects
Escrache ,Representante público ,Legitimidad de origen y de ejercicio ,Derecho de manifestación ,Libertad de expresión ,Derecho a la vida privada y al domicilio. Key words: Escrache. Public representative. Legitimacy in origin. Legitimacy in exercise. Rig ,Law of Europe ,KJ-KKZ ,Law in general. Comparative and uniform law. Jurisprudence ,K1-7720 - Abstract
La reciente práctica de los escraches en España, en el contexto de la crisis económica, ha planteado un complejo debate en torno a la confrontación entre derechos fundamentales. En efecto, de un lado, debe tenerse en cuenta el derecho al libre ejercicio de un cargo público y los derechos de la personalidad (integridad, vida privada y familiar o disfrute pacífico del domicilio) cuando no se actúa en calidad de representante público. De otro lado, debe tomarse en consideración el ejercicio de otros derechos fundamentales (expresión, manifestación) por parte de quienes llevan a cabo los escraches. El presente trabajo pretende analizar los conflictos entre esos derechos fundamentales con el fin de ofrecer unas respuestas ponderadas, las cuales concluyen con un «no» al escrache y un «sí» a la manifestación. Abstract: The recent practice of «escraches» in Spain, in the context of the economic crisis, has raised a complex debate about the confrontation between fundamental rights. Indeed, on one hand, it must be taken into account the right to free exercise of public office as well as personality rights (integrity, private and family life and peaceful enjoyment of the home) when not acting as a public representative. On the other hand, it must be taken in consideration the exercise of other fundamental rights (expression, demonstration) by those who perform escraches. This paper intends to analyze the conflicts between these fundamental rights in order to provide balanced responses, which lead to the following conclusion: «no» to escrache and «yes» to demostration.
- Published
- 2015
- Full Text
- View/download PDF
6. Novel fuzzy adaptive sensorless induction motor drive
- Author
-
Lopez, Jordi Catala i, Romeral, Luis, Arias, Antoni, and Aldabas, Emiliano
- Subjects
Induction electric motors -- Research ,Control systems -- Research ,Business ,Computers ,Electronics ,Electronics and electrical industries - Abstract
Investigations were carried out on a novel sensorless drive for induction motors, based on the combination of an open-loop (OL) estimator and a steady-state (SS) estimator. The novelty of this new sensorless structure is obtained by an intelligent mixing of the OL estimator response with the SS one. A fuzzy system weights the two estimated speed values according to the motor operating point. Then, the final speed value is obtained averaging the previously weighted speed values. Moreover, the OL estimator response is improved by means of using a fuzzy-controlled adaptive filter that selects the optimum cutoff frequency. The aim of this paper is to obtain a moderate performance sensorless drive for induction motors that could be easily implemented for industrial applications without a high computational effort. Simulation and experimental results illustrate the operation and performance of the proposed fuzzy-logic-based sensorless drive. Index Terms--Fuzzy control, induction motors, sensorless.
- Published
- 2006
7. Primary total hip arthroplasty with a fully porous-coated uncemented stem: up to twenty-eight years. Retrospective cohort study
- Author
-
Sahun-Mairal, B., primary, Agullo-Ferre, J. L., additional, Rodriguez-Perez, D., additional, Garreta-Catala, I., additional, Tramunt-Monsonet, C., additional, Videla, S., additional, and Coscujuela-Maña, A., additional
- Published
- 2021
- Full Text
- View/download PDF
8. O-023 - EXPERIENCIA INICIAL Y CURVA DE APRENDIZAJE DURANTE LOS 100 PRIMEROS CASOS EN LA INSTRUMENTACIÓN DE COLUMNA ROBÓTICA
- Author
-
de la Fuente, P., Varela, M.D., Zabaleta, I., Catalá, I., and Clavel, P.
- Published
- 2023
- Full Text
- View/download PDF
9. Linfogammagrafía y biopsia del ganglio centinela en el carcinoma no palpable de mama
- Author
-
Benítez Segura, A., Bajén Lázaro, M.T., Rodríguez-Gasén, A., Guirao, S., Ferran, N., Ricart, Y., Mora, J., Prieto, L., Plà, M.J., Palacín, J.A., Català, I., Gil Gil, M., and Martín-Comín, J.
- Published
- 2006
- Full Text
- View/download PDF
10. TRANSCAVAL ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION FOR A LYMPHOMA DIAGNOSIS
- Author
-
Garcia-Sumalla, A, additional, Maisterra, S, additional, Catala, I, additional, and Gornals, JB, additional
- Published
- 2020
- Full Text
- View/download PDF
11. Whole-body protein turnover in humans fed a soy protein-rich vegetable diet
- Author
-
Gausserès, N, Catala, I, Mahé, S, Luengo, C, Bornet, F, Guy-Grand, B, and Tomé, D
- Published
- 1997
- Full Text
- View/download PDF
12. Diet, Length of Gestation, and Fecal Short Chain Fatty Acids in Healthy Premature Neonates
- Author
-
Favre, A., Szylit, O., Popot, F., Catala, I., Rondeau, C., Maurage, C., Gold, F., Borderon, J.C., and Butel, M.J.
- Published
- 2002
13. Voluntad política para un tiempo de reformas: Presupuestos previos para abordar una reforma constitucional
- Author
-
Catala i Bas, Alexandre H., primary
- Published
- 2019
- Full Text
- View/download PDF
14. SPEED ESTIMATOR WITH ADAPTATIVE FUZZY FILTER
- Author
-
López, J. Català i, Martínez, L. Romeral, Pujol, A. Arias, and Aldabas, E.
- Published
- 2002
- Full Text
- View/download PDF
15. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
- Author
-
Mateo, F, Arenas, EJ, Aguilar, H, Serra-Musach, J, Garibay, GR, Boni, J, Maicas, M, Du, S, Iorio, F, Herranz-Ors, C, Islam, A, Prado, X, Llorente, A, Petit, A, Vidal, A, Catala, I, Soler, T, Venturas, G, Rojo-Sebastian, A, Serra, H, Cuadras, D, Blanco, I, Lozano, J, Canals, F, Sieuwerts, Anieta, Weerd, Vanja, Look, MP, Puertas, S, Garcia, N, Perkins, AS, Bonifaci, N, Skowron, M, Gomez-Baldo, L, Hernandez, V, Martinez-Aranda, A, Martinez-Iniesta, M, Serrat, X, Ceron, J, Brunet, J, Barretina, MP, Gil, M, Falo, C, Fernandez, A, Morilla, I, Pernas, S, Pla, MJ, Andreu, X, Segui, MA, Ballester, R, Castella, E, Nellist, Mark, Morales, S, Valls, J, Velasco, A, Matias-Guiu, X, Figueras, A, Sanchez-Mut, JV, Sanchez-Cespedes, M, Cordero, A, Gomez-Miragaya, J, Palomero, L, Gomez, A, Gajewski, TF, Cohen, EEW, Jesiotr, M, Bodnar, L, Quintela-Fandino, M, Lopez-Bigas, N, Valdes-Mas, R, Puente, XS, Vinals, F, Casanovas, O, Graupera, M, Hernandez-Losa, J, Cajal, SRY, Garcia-Alonso, L, Saez-Rodriguez, J, Esteller, M, Sierra, A, Martin-Martin, N, Matheu, A, Carracedo, A, Gonzalez-Suarez, E, Nanjundan, M, Cortes, J, Lazaro, C (Conxi), Odero, MD, Martens, John, Moreno-Bueno, G, Barcellos-Hoff, MH, Villanueva, A, Gomis, RR, Pujana, MA, Mateo, F, Arenas, EJ, Aguilar, H, Serra-Musach, J, Garibay, GR, Boni, J, Maicas, M, Du, S, Iorio, F, Herranz-Ors, C, Islam, A, Prado, X, Llorente, A, Petit, A, Vidal, A, Catala, I, Soler, T, Venturas, G, Rojo-Sebastian, A, Serra, H, Cuadras, D, Blanco, I, Lozano, J, Canals, F, Sieuwerts, Anieta, Weerd, Vanja, Look, MP, Puertas, S, Garcia, N, Perkins, AS, Bonifaci, N, Skowron, M, Gomez-Baldo, L, Hernandez, V, Martinez-Aranda, A, Martinez-Iniesta, M, Serrat, X, Ceron, J, Brunet, J, Barretina, MP, Gil, M, Falo, C, Fernandez, A, Morilla, I, Pernas, S, Pla, MJ, Andreu, X, Segui, MA, Ballester, R, Castella, E, Nellist, Mark, Morales, S, Valls, J, Velasco, A, Matias-Guiu, X, Figueras, A, Sanchez-Mut, JV, Sanchez-Cespedes, M, Cordero, A, Gomez-Miragaya, J, Palomero, L, Gomez, A, Gajewski, TF, Cohen, EEW, Jesiotr, M, Bodnar, L, Quintela-Fandino, M, Lopez-Bigas, N, Valdes-Mas, R, Puente, XS, Vinals, F, Casanovas, O, Graupera, M, Hernandez-Losa, J, Cajal, SRY, Garcia-Alonso, L, Saez-Rodriguez, J, Esteller, M, Sierra, A, Martin-Martin, N, Matheu, A, Carracedo, A, Gonzalez-Suarez, E, Nanjundan, M, Cortes, J, Lazaro, C (Conxi), Odero, MD, Martens, John, Moreno-Bueno, G, Barcellos-Hoff, MH, Villanueva, A, Gomis, RR, and Pujana, MA
- Published
- 2017
16. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers
- Author
-
Blanco, I., Kuchenbaecker, K., Cuadras, D., Wang, X.S., Barrowdale, D., Garibay, G.R., Librado, P., Sanchez-Gracia, A., Rozas, J., Bonifaci, N., McGuffog, L., Pankratz, V.S., Islam, A., Mateo, F., Berenguer, A., Petit, A., Catala, I., Brunet, J., Feliubadalo, L., Tornero, E., Benitez, J., Osorio, A., Cajal, T.R.Y., Nevanlinna, H., Aittomaki, K., Arun, B.K., Toland, A.E., Karlan, B.Y., Walsh, C., Lester, J., Greene, M.H., Mai, P.L., Nussbaum, R.L., Andrulis, I.L., Domchek, S.M., Nathanson, K.L., Rebbeck, T.R., Barkardottir, R.B., Jakubowska, A., Lubinski, J., Durda, K., Jaworska-Bieniek, K., Claes, K., Maerken, T. van, Diez, O., Hansen, T.V., Jonson, L., Gerdes, A.M., Ejlertsen, B., Hoya, M. de la, Caldees, T., Dunning, A.M., Oliver, C., Fineberg, E., Cook, M., Peock, S., McCann, E., Murray, A., Jacobs, C., Pichert, G., Lalloo, F., Chu, C., Dorkins, H., Paterson, J., Ong, K.R., Teixeira, M.R., Teixeira, Hogervorst, F.B.L., Hout, A.H. van der, Seynaeve, C., Luijt, R.B. van der, Ligtenberg, M.J.L., Devilee, P., Wijnen, J.T., Rookus, M.A., Meijers-Heijboer, H.E.J., Blok, M.J., Ouweland, A.M.W. van den, Aalfs, C.M., Rodriguez, G.C., Phillips, K.A.A., Piedmonte, M., Nerenstone, S.R., Bae-Jump, V.L., O'Malley, D.M., Ratner, E.S., Schmutzler, R.K., Wappenschmidt, B., Rhiem, K., Engel, C., Meindl, A., Ditsch, N., Arnold, N., Plendl, H.J., Niederacher, D., Sutter, C., Wang-Gohrke, S., Steinemann, D., Preisler-Adams, S., Kast, K., Varon-Mateeva, R., Gehrig, A., Bojesen, A., Pedersen, I.S., Sunde, L., Jensen, U.B., Thomassen, M., Kruse, T.A., Foretova, L., Peterlongo, P., Bernard, L., Peissel, B., Scuvera, G., Manoukian, S., Radice, P., Ottini, L., Montagna, M., Agata, S., Maugard, C., Simard, J., Soucy, P., Berger, A., Fink-Retter, A., Singer, C.F., Rappaport, C., Geschwantler-Kaulich, D., Tea, M.K., Pfeiler, G., John, E.M., Miron, A., Neuhausen, S.L., Terry, M.B., Chung, W.K., Daly, M.B., Goldgar, D.E., Janavicius, R., Dorfling, C.M., Rensburg, E.J. van, Fostira, F., Konstantopoulou, I., Garber, J., Godwin, A.K., Olah, E., Narod, S.A., Rennert, G., Paluch, S.S., Laitman, Y., Friedman, E., Liljegren, A., Rantala, J., Stenmark-Askmalm, M., Loman, N., Imyanitov, E.N., Hamann, U., Spurdle, A.B., Healey, S., Weitzel, J.N., Herzog, J., Margileth, D., Gorrini, C., Esteller, M., Gomez, A., Sayols, S., Vidal, E., Heyn, H., Stoppa-Lyonnet, Leone, M., Barjhoux, L., Fassy-Colcombet, M., Pauw, A. de, Lasset, C., Ferrer, S.F., Castera, L., Berthet, P., Cornelis, F., Bignon, Y.J., Damiola, F., Mazoyer, S., Sinilnikova, O.M., Maxwell, C.A., Vijai, J., Robson, M., Kauff, N., Corines, M.J., Villano, D., Cunningham, J., Lee, A., Lindor, N., Lazaro, C., Easton, D.F., Offit, K., Chenevix-Trench, G., Couch, F.J., Antoniou, A.C., Pujana, M.A., BCFR, SWE-BRCA, KConFab Investigators, GEMO, Human genetics, CCA - Oncogenesis, Medical Oncology, Clinical Genetics, Suzuki, Hiromu, MUMC+: DA KG Lab Centraal Lab (9), RS: GROW - Oncology, RS: GROW - R4 - Reproductive and Perinatal Medicine, CCA -Cancer Center Amsterdam, ARD - Amsterdam Reproduction and Development, Human Genetics, Department of Obstetrics and Gynecology, Clinicum, Medicum, Haartman Institute (-2014), and Department of Medical and Clinical Genetics
- Subjects
single nucleotide ,Oncology ,Carcinogenesis ,TUBG1 ,Genes, BRCA2 ,Genes, BRCA1 ,Càncer d'ovari ,MODIFIERS ,Genome-wide association study ,Cell Cycle Proteins ,Breast cancer ,mammary glands ,Aetiology ,genes ,skin and connective tissue diseases ,Cancer ,Extracellular Matrix Proteins ,Hazard ratio ,CHIP-SEQ ,3. Good health ,ddc ,Hyaluronan Receptors ,Medicine ,Teixeira ,Human ,medicine.medical_specialty ,Evolution ,Science ,Non-P.H.S ,Single-nucleotide polymorphism ,Evolution, Molecular ,SDG 3 - Good Health and Well-being ,Ovarian cancer ,Genetics ,biochemistry ,Humans ,human ,CELL ,Polymorphism ,GENOME-WIDE ASSOCIATION ,medicine (all) ,Retrospective Studies ,Cancer och onkologi ,Prevention ,Mutació (Biologia) ,Biology and Life Sciences ,Molecular ,SWE-BRCA ,BRCA1 ,medicine.disease ,BRCA2 ,POLYMORPHISM ,Genes ,Genetic Loci ,Cancer and Oncology ,Mutation ,U.S. Gov't ,Bioinformatics ,medicine.disease_cause ,3123 Gynaecology and paediatrics ,Tubulin ,Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14] ,ELEMENTS ,2.1 Biological and endogenous factors ,CD44 ,Non-U.S. Gov't ,Aurora Kinase A ,Likelihood Functions ,Multidisciplinary ,Research Support, Non-U.S. Gov't ,agricultural and biological sciences (all) ,genetics and molecular biology (all) ,BCFR ,Nuclear Proteins ,Single Nucleotide ,Mammary Glands ,SURVIVAL ,kConFab Investigators ,Female ,Microtubule-Associated Proteins ,Research Article ,Antigens, CD44 ,aurora kinase A ,breast neoplasms ,carcinogenesis ,cell cycle proteins ,estrogen receptor alpha ,evolution, molecular ,extracellular matrix proteins ,female ,genetic loci ,genetic predisposition to disease ,humans ,likelihood functions ,mammary glands, human ,microtubule-associated proteins ,nuclear proteins ,polymorphism ,retrospective studies ,tubulin ,genes, BRCA1 ,genes, BRCA2 ,mutation ,biochemistry, genetics and molecular biology (all) ,SUSCEPTIBILITY LOCI ,General Science & Technology ,3122 Cancers ,Breast Neoplasms ,Biology ,Research Support ,Polymorphism, Single Nucleotide ,N.I.H ,GENETIC INTERACTION NETWORKS ,Càncer de mama ,EXPRESSION SIGNATURE ,Amino acid sequence ,Research Support, N.I.H., Extramural ,Internal medicine ,Seqüència d'aminoàcids ,evolution ,Genetic variation ,Journal Article ,medicine ,Genetic Predisposition to Disease ,ddc:610 ,molecular ,Antigens ,Mammary Glands, Human ,ddc:611 ,Intramural ,Estrogen Receptor alpha ,Extramural ,Mutation (Biology) ,Research Support, N.I.H., Intramural ,3111 Biomedicine ,GEMO ,Research Support, U.S. Gov't, Non-P.H.S - Abstract
While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04 - 1.15, p = 1.9 x 10(-4) (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03 - 1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted p(interaction) values greater than 0.05) for deviations from the multiplicative model for rs299290 and CSTF1 rs6064391, and rs299290 and TUBG1 rs11649877 in both BRCA1 and BRCA2 mutation carriers. Following these suggestions, the expression of HMMR and AURKA or TUBG1 in sporadic breast tumors was found to potentially interact, influencing patients survival. Together, the results of this study support the hypothesis of a causative link between altered function of AURKA-HMMR-TPX2-TUBG1 and breast carcinogenesis in BRCA1/2 mutation carriers. Funding Agencies|National Cancer Institute [UM1 CA164920]; Lithuania (BFBOCC-LT): Research Council of Lithuania grant [LIG-07/2012]; Hereditary Cancer Association (Paveldimo vezio asociacija); LSC grant [10.0010.08]; ESF [2009/0220/1DP/1.1.1.2.0/09/APIA/VIAA/016]; Liepajas municipal council; Cancer Association of South Africa (CANSA); Morris and Horowitz Familes Endowed Professorship; NEYE Foundation; Spanish Association against Cancer [AECC08, RTICC 06/0020/1060, FISPI08/1120]; Mutua Madrilena Foundation (FMMA); COH-CCGCRN: City of Hope Clinical Cancer Genetics Community Network from the National Cancer Institute and the Office of the Director, National Institutes of Health; Hereditary Cancer Research Registry from the National Cancer Institute and the Office of the Director, National Institutes of Health [RC4CA153828]; Fondazione IRCCS Istituto Nazionale Tumori; Cancer Research-United Kingdom grant [C12292/A11174, C1287/ A10118]; NHMRC Program Grant; DKFZ; European Union (European Social Fund-ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program of the General Secretariat for Research and Technology: ARISTEIA; European Social Fund; Cancer Research United Kingdom Grants [C1287/A10118, C1287/A11990]; National Institute of Health Research (NIHR) grant; NIHR grant; Royal Marsden NHS Foundation Trust; Cancer Research United Kingdom Grant [C5047/A8385]; University of Kansas Cancer Center [P30 CA168524]; Kansas Bioscience Authority Eminent Scholar Program; Chancellors Distinguished Chair in Biomedical Sciences Professorship; AKG [5U01CA113916, R01CA140323]; German Cancer Aid [109076]; Center for Molecular Medicine Cologne (CMMC); Ligue National Contre le Cancer; Association "Le cancer du sein, parlonsen!" Award; Canadian Institutes of Health Research; Fund for Scientific Research Flanders (FWO); National Cancer Institute grant [CA 27469]; GOG Statistical and Data Center [CA 37517]; GOGs Cancer Prevention and Control Committee [CA 101165]; Intramural Research Program, NCI; ISCIII (Spain) [RD12/00369/0006, 12/00539]; European Regional Development FEDER funds; Helsinki University Central Hospital Research Fund; Academy of Finland [132473]; Finnish Cancer Society; Sigrid Juselius Foundation; Dutch Cancer Society grant [NKI1998-1854, NKI2004-3088, NKI2007-3756]; Netherlands Organization of Scientific Research [NWO 91109024]; Pink Ribbon grant [110005]; BBMRI grant [NWO 184.021.007/CP46]; Hungarian Research Grant [KTIA-OTKA CK-80745]; Norwegian EEA Financial Mechanism [HU0115/NA/2008-3/OP-9]; Spanish Ministry of Health ISCIII FIS [PI10/01422, PI12/01528, PI13/00285]; RTICC [RD12/0036/0008]; Ramon Areces (XV) Foundation; Eugenio Rodriguez Pascual Foundation; Roses Contra el Cancer Foundation; Spanish Association Against Cancer (AECC); AGAUR Generalitat de Catalunya [2009-SGR290, 2009-SGR293]; Polish Foundation of Science; Icelandic Association "Walking for Breast Cancer Research"; Nordic Cancer Union; Landspitali University Hospital Research Fund; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program; Canadian Breast Cancer Research Alliance-grant [019511]; Ministry of Economic Development, Innovation and Export Trade-grant [PSR-SIIRI-701]; Ministero dellIstruzione, dellUniversita e della Ricerca and Ministero della Salute; Liga Portuguesa Contra o Cancro; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC); Queensland Cancer Fund; Cancer Council of New South Wales; Cancer Council of Victoria; Cancer Foundation of Western Australia; Cancer Councils of Tasmania; National Institutes of Health grant [CA128978]; NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]; United States Department of Defence Ovarian Cancer Idea award [W81XWH-10-1-0341]; Breast Cancer Research Foundation; Jewish General Hospital Weekend; Quebec Ministry of Economic Development, Innovation and Export Trade; Cancer Councils of South Australia; European Regional Development Fund; State Budget of the Czech Republic (RECAMO) [CZ.1.05/2.1.00/03.0101]; MH CZ-DRO (MMCI) [00209805]; Niehaus Family Genetics Research Fund; STARR Cancer Consortium Grant; NAROD [1R01 CA149429-01]; NCI Intramural Research Program, National Institutes of Health [NO2-CP-11019-50, N02-CP-65504]; Westat, Inc, Rockville, Maryland; Clalit Health Services in Israel; Israel Cancer Association; Breast Cancer Research Foundation (BCRF), New York; Russian Federation for Basic Research [11-04-00227, 12-04-00928, 12-04-01490]; Federal Agency for Science and Innovations, Russia [02.740.11.0780]; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program and grant from the National Cancer Institute [UM1 CA164920]; Breast Cancer Family Registry (BCFR); United States Government or the BCFR; Ohio State University Comprehensive Cancer Center; Isreal cancer association; Israeli Inherited breast cancer consortium; Swedish Cancer Society; Ralph and Marion Falk Medical Research Trust; Entertainment Industry Fund National Womens Cancer Research Alliance; National Institutes of Health (NIH) [R01-CA102776, R01-CA083855]; Rooney Family Foundation; Susan G. Komen Foundation for the cure, Basser Research Center; American Cancer Society Early Detection Professorship [SIOP-06-258-01-COUN]; SAF2010-20493; [PBZ_KBN_122/P05/2004]
- Published
- 2015
- Full Text
- View/download PDF
17. P2.03-03 Landscape of Gene Fusions in Lung Adenocarcinoma Patients with Minimal Cigarette Exposure Identified on Malignant Pleural Effusions
- Author
-
Saigi, M., Pros, E., Béjar, J.J. Alburquerque, Català, I., Verdura, S., Sánchez, R. Palmero, Jove, M., Nadal, E., and Sanchez-Cespedes, M.
- Published
- 2019
- Full Text
- View/download PDF
18. P1.03-26 Genetic and Molecular Profiling of Non-Smoking Related Lung Adenocarcinomas
- Author
-
Pros, E., Saigi, M., Béjar, J.J. Alburquerque, Pajares, M.J., Martinez-Delgado, B., Carretero, J., Tonda, R., Esteve-Codina, A., Verdura, S., Català, I., Reguart, N., Juan, O., Nadal, E., Felip, E., Montuenga, L., and Sanchez-Cespedes, M.
- Published
- 2019
- Full Text
- View/download PDF
19. Newborns Whose Mother Has Autoimmune Disease. A Community Hospitals’ Experience
- Author
-
Sanchez-Manubens, Judith, Ortiz-Santamaria, Vera, Coll Sibina, Maria Teresa, Cuquet, Jordi, Bermudez, Jorge René, Surís, Xavier, and Català i Puigbó, Margarida
- Published
- 2013
- Full Text
- View/download PDF
20. Recién nacidos de madre con enfermedad autoinmunitaria. Experiencia en un hospital comarcal
- Author
-
Sanchez-Manubens, Judith, Ortiz-Santamaria, Vera, Coll Sibina, Maria Teresa, Cuquet, Jordi, Bermudez, Jorge René, Surís, Xavier, and Català i Puigbó, Margarida
- Published
- 2013
- Full Text
- View/download PDF
21. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers
- Author
-
Blanco, I, Kuchenbaecker, K, Cuadras, D, Wang, XS, Barrowdale, D, Garibay, GR, Librado, P, Sanchez-Gracia, A, Rozas, J, Bonifaci, N, McGuffog, L, Pankratz, VS, Islam, A, Mateo, F, Berenguer, A, Petit, A, Catala, I, Brunet, J, Feliubadalo, L, Tornero, E, Benitez, J, Osorio, A, Cajal, TRY, Nevanlinna, H, Aittomaki, K, Arun, BK, Toland, AE, Karlan, BY, Walsh, C, Lester, J, Greene, MH, Mai, PL, Nussbaum, RL, Andrulis, IL, Domchek, SM, Nathanson, KL, Rebbeck, TR, Barkardottir, RB, Jakubowska, A, Lubinski, J, Durda, K, Jaworska-Bieniek, K, Claes, K, Van Maerken, T, Diez, O, Hansen, TV, Jonson, L, Gerdes, AM, Ejlertsen, B, de la Hoya, M, Caldees, T, Dunning, AM, Oliver, C, Fineberg, E, Cook, M, Peock, S, McCann, E, Murray, A, Jacobs, C, Pichert, G, Lalloo, F, Chu, C, Dorkins, H, Paterson, J, Ong, KR, Teixeira, MR, Teixeira, Hogervorst, FBL, van der Hout, AH, Seynaeve, Caroline, van der Luijt, RB, Ligtenberg, MJL, Devilee, P, Wijnen, JT, Rookus, MA, Meijers-Heijboer, HEJ, Blok, MJ, van den Ouweland, Ans, Aalfs, CM, Rodriguez, GC, Phillips, KAA, Piedmonte, M, Nerenstone, SR, Bae-Jump, VL, O'Malley, DM, Ratner, ES, Schmutzler, RK, Wappenschmidt, B, Rhiem, K, Engel, C, Meindl, A, Ditsch, N, Arnold, N, Plendl, HJ, Niederacher, D, Sutter, C, Wang-Gohrke, S, Steinemann, D, Preisler-Adams, S, Kast, K, Varon-Mateeva, R, Gehrig, A, Bojesen, A, Pedersen, IS, Sunde, L, Jensen, UB, Thomassen, Marga, Kruse, TA, Foretova, L, Peterlongo, P, Bernard, L, Peissel, B, Scuvera, G, Manoukian, S, Radice, P, Ottini, L, Montagna, M, Agata, S, Maugard, C, Simard, J, Soucy, P, Berger, A, Fink-Retter, A, Singer, CF, Rappaport, C, Geschwantler-Kaulich, D, Tea, MK, Pfeiler, G, John, EM, Miron, A, Neuhausen, SL, Terry, MB, Chung, WK, Daly, MB, Goldgar, DE, Janavicius, R, Dorfling, CM, van Rensburg, EJ, Fostira, F, Konstantopoulou, I, Garber, J, Godwin, AK, Olah, E, Narod, SA, Rennert, G, Paluch, SS, Laitman, Y, Friedman, E, Liljegren, A, Rantala, J, Stenmark-Askmalm, M, Loman, N, Imyanitov, EN, Hamann, U, Spurdle, AB, Healey, S, Weitzel, JN, Herzog, J, Margileth, D, Gorrini, C, Esteller, M, Gomez, A, Sayols, S, Vidal, E, Heyn, H, Stoppa-Lyonnet, Leone, M, Barjhoux, L, Fassy-Colcombet, M, de Pauw, A, Lasset, C, Ferrer, SF, Castera, L, Berthet, P, Cornelis, F, Bignon, YJ, Damiola, F, Mazoyer, S, Sinilnikova, OM, Maxwell, CA, Vijai, J, Robson, M, Kauff, N, Corines, MJ, Villano, D, Cunningham, J, van der Lee, A, Lindor, N, Lazaro, C (Conxi), Easton, DF, Offit, K, Chenevix-Trench, G, Couch, FJ, Antoniou, AC, Pujana, MA, Blanco, I, Kuchenbaecker, K, Cuadras, D, Wang, XS, Barrowdale, D, Garibay, GR, Librado, P, Sanchez-Gracia, A, Rozas, J, Bonifaci, N, McGuffog, L, Pankratz, VS, Islam, A, Mateo, F, Berenguer, A, Petit, A, Catala, I, Brunet, J, Feliubadalo, L, Tornero, E, Benitez, J, Osorio, A, Cajal, TRY, Nevanlinna, H, Aittomaki, K, Arun, BK, Toland, AE, Karlan, BY, Walsh, C, Lester, J, Greene, MH, Mai, PL, Nussbaum, RL, Andrulis, IL, Domchek, SM, Nathanson, KL, Rebbeck, TR, Barkardottir, RB, Jakubowska, A, Lubinski, J, Durda, K, Jaworska-Bieniek, K, Claes, K, Van Maerken, T, Diez, O, Hansen, TV, Jonson, L, Gerdes, AM, Ejlertsen, B, de la Hoya, M, Caldees, T, Dunning, AM, Oliver, C, Fineberg, E, Cook, M, Peock, S, McCann, E, Murray, A, Jacobs, C, Pichert, G, Lalloo, F, Chu, C, Dorkins, H, Paterson, J, Ong, KR, Teixeira, MR, Teixeira, Hogervorst, FBL, van der Hout, AH, Seynaeve, Caroline, van der Luijt, RB, Ligtenberg, MJL, Devilee, P, Wijnen, JT, Rookus, MA, Meijers-Heijboer, HEJ, Blok, MJ, van den Ouweland, Ans, Aalfs, CM, Rodriguez, GC, Phillips, KAA, Piedmonte, M, Nerenstone, SR, Bae-Jump, VL, O'Malley, DM, Ratner, ES, Schmutzler, RK, Wappenschmidt, B, Rhiem, K, Engel, C, Meindl, A, Ditsch, N, Arnold, N, Plendl, HJ, Niederacher, D, Sutter, C, Wang-Gohrke, S, Steinemann, D, Preisler-Adams, S, Kast, K, Varon-Mateeva, R, Gehrig, A, Bojesen, A, Pedersen, IS, Sunde, L, Jensen, UB, Thomassen, Marga, Kruse, TA, Foretova, L, Peterlongo, P, Bernard, L, Peissel, B, Scuvera, G, Manoukian, S, Radice, P, Ottini, L, Montagna, M, Agata, S, Maugard, C, Simard, J, Soucy, P, Berger, A, Fink-Retter, A, Singer, CF, Rappaport, C, Geschwantler-Kaulich, D, Tea, MK, Pfeiler, G, John, EM, Miron, A, Neuhausen, SL, Terry, MB, Chung, WK, Daly, MB, Goldgar, DE, Janavicius, R, Dorfling, CM, van Rensburg, EJ, Fostira, F, Konstantopoulou, I, Garber, J, Godwin, AK, Olah, E, Narod, SA, Rennert, G, Paluch, SS, Laitman, Y, Friedman, E, Liljegren, A, Rantala, J, Stenmark-Askmalm, M, Loman, N, Imyanitov, EN, Hamann, U, Spurdle, AB, Healey, S, Weitzel, JN, Herzog, J, Margileth, D, Gorrini, C, Esteller, M, Gomez, A, Sayols, S, Vidal, E, Heyn, H, Stoppa-Lyonnet, Leone, M, Barjhoux, L, Fassy-Colcombet, M, de Pauw, A, Lasset, C, Ferrer, SF, Castera, L, Berthet, P, Cornelis, F, Bignon, YJ, Damiola, F, Mazoyer, S, Sinilnikova, OM, Maxwell, CA, Vijai, J, Robson, M, Kauff, N, Corines, MJ, Villano, D, Cunningham, J, van der Lee, A, Lindor, N, Lazaro, C (Conxi), Easton, DF, Offit, K, Chenevix-Trench, G, Couch, FJ, Antoniou, AC, and Pujana, MA
- Abstract
While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04 - 1.15, p = 1.9 x 10(-4) (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03 - 1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted p(interaction) values > 0.05) for deviations from the multiplicative model for rs299290 and CSTF1 rs6064391, and rs299290 and TUBG1 rs11649877 in both BRCA1 and BRCA2 mutation carriers. Following these suggestions, the expression of HMMR and AURKA or TUBG1 in sporadic breast tumors was found to potentially interact, influencing patients' survival. Together, the results of this study support the hypothesis of a causative link between altered function of AURKA-HMMR-TPX2-TUBG1 and breast carcinogenesis in BRCA1/2 mutation carriers.
- Published
- 2015
22. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
- Author
-
Maxwell, C.A., Benitez, J., Gomez-Baldo, L., Osorio, A., Bonifaci, N., Fernandez-Ramires, R., Costes, S.V., Guino, E., Chen, H., Evans, G.J., Mohan, P., Catala, I., Petit, A., Aguilar, H., Villanueva, A., Aytes, A., Serra-Musach, J., Rennert, G., Lejbkowicz, F., Peterlongo, P., Manoukian, S., Peissel, B., Ripamonti, C.B., Bonanni, B., Viel, A., Allavena, A., Bernard, L., Radice, P., Friedman, E., Kaufman, B., Laitman, Y., Dubrovsky, M., Milgrom, R., Jakubowska, A., Cybulski, C., Gorski, B., Jaworska, K., Durda, K., Sukiennicki, G., Lubinski, J., Shugart, Y.Y., Domchek, S.M., Letrero, R., Weber, B.L., Hogervorst, F.B.L., Rookus, M.A., Collee, J.M., Devilee, P., Ligtenberg, M.J.L., Luijt, R.B. van der, Aalfs, C.M., Waisfisz, Q., Wijnen, J., Roozendaal, C.E.P. van, Easton, D.F., Peock, S., Cook, M., Oliver, C., Frost, D., Harrington, P., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Chu, C., Eccles, D., Douglas, F., Brewer, C., Nevanlinna, H., Heikkinen, T., Couch, F.J., Lindor, N.M., Wang, X., Godwin, A.K., Caligo, M.A., Lombardi, G., Loman, N., Karlsson, P., Ehrencrona, H., Wachenfeldt, A. von, Bjork Barkardottir, R., Hamann, U., Rashid, M.U., Lasa, A., Caldes, T., Andres, R., Schmitt, M., Assmann, V., Stevens, K., Offit, K., Curado, J., Tilgner, H., Guigo, R., Aiza, G., Brunet, J., Castellsague, J., Martrat, G., Urruticoechea, A., Blanco, I., and Tihomirova, L.
- Subjects
Hereditary cancer and cancer-related syndromes [ONCOL 1] ,Translational research [ONCOL 3] ,skin and connective tissue diseases ,Genetics and epigenetic pathways of disease Translational research [NCMLS 6] - Abstract
Contains fulltext : 98031.pdf (Publisher’s version ) (Open Access) Differentiated mammary epithelium shows apicobasal polarity, and loss of tissue organization is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of stem and progenitor cells in normal breast tissue and increased risk of developing tumors of basal-like type suggest that BRCA1 regulates stem/progenitor cell proliferation and differentiation. However, the function of BRCA1 in this process and its link to carcinogenesis remain unknown. Here we depict a molecular mechanism involving BRCA1 and RHAMM that regulates apicobasal polarity and, when perturbed, may increase risk of breast cancer. Starting from complementary genetic analyses across families and populations, we identified common genetic variation at the low-penetrance susceptibility HMMR locus (encoding for RHAMM) that modifies breast cancer risk among BRCA1, but probably not BRCA2, mutation carriers: n = 7,584, weighted hazard ratio ((w)HR) = 1.09 (95% CI 1.02-1.16), p(trend) = 0.017; and n = 3,965, (w)HR = 1.04 (95% CI 0.94-1.16), p(trend) = 0.43; respectively. Subsequently, studies of MCF10A apicobasal polarization revealed a central role for BRCA1 and RHAMM, together with AURKA and TPX2, in essential reorganization of microtubules. Mechanistically, reorganization is facilitated by BRCA1 and impaired by AURKA, which is regulated by negative feedback involving RHAMM and TPX2. Taken together, our data provide fundamental insight into apicobasal polarization through BRCA1 function, which may explain the expanded cell subsets and characteristic tumor type accompanying BRCA1 mutation, while also linking this process to sporadic breast cancer through perturbation of HMMR/RHAMM.
- Published
- 2011
23. ROL DE LA PUNCIÓN ASPIRATIVA GUIADA POR ECOENDOSCOPIA EN EL ESTUDIO DE LA GLÁNDULA SUPRARRENAL
- Author
-
Gallarreta, V, primary, Consiglieri, C, additional, De La Hera, M, additional, Sanchez-Salido Lia, T, additional, Llatjos, R, additional, Baixeras, N, additional, Catala, I, additional, and Gornals, JB, additional
- Published
- 2015
- Full Text
- View/download PDF
24. La confrontación de derechos en los escraches
- Author
-
Catala i Bas, Alexandre H., primary
- Published
- 2015
- Full Text
- View/download PDF
25. La jurisprudencia del TEDH sobre el derecho a un proceso sin dilaciones indebidas y su recepción por el Tribunal Constitucional
- Author
-
Catala i Bas, Alexandre H.
- Published
- 2002
26. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
- Author
-
Ashworth, A, Maxwell, CA, Benitez, J, Gomez-Baldo, L, Osorio, A, Bonifaci, N, Fernandez-Ramires, R, Costes, SV, Guino, E, Chen, H, Evans, GJR, Mohan, P, Catala, I, Petit, A, Aguilar, H, Villanueva, A, Aytes, A, Serra-Musach, J, Rennert, G, Lejbkowicz, F, Peterlongo, P, Manoukian, S, Peissel, B, Ripamonti, CB, Bonanni, B, Viel, A, Allavena, A, Bernard, L, Radice, P, Friedman, E, Kaufman, B, Laitman, Y, Dubrovsky, M, Milgrom, R, Jakubowska, A, Cybulski, C, Gorski, B, Jaworska, K, Durda, K, Sukiennicki, G, Lubinski, J, Shugart, YY, Domchek, SM, Letrero, R, Weber, BL, Hogervorst, FBL, Rookus, MA, Collee, JM, Devilee, P, Ligtenberg, MJ, van der Luijt, RB, Aalfs, CM, Waisfisz, Q, Wijnen, J, van Roozendaal, CEP, Easton, DF, Peock, S, Cook, M, Oliver, C, Frost, D, Harrington, P, Evans, DG, Lalloo, F, Eeles, R, Izatt, L, Chu, C, Eccles, D, Douglas, F, Brewer, C, Nevanlinna, H, Heikkinen, T, Couch, FJ, Lindor, NM, Wang, X, Godwin, AK, Caligo, MA, Lombardi, G, Loman, N, Karlsson, P, Ehrencrona, H, von Wachenfeldt, A, Barkardottir, RB, Hamann, U, Rashid, MU, Lasa, A, Caldes, T, Andres, R, Schmitt, M, Assmann, V, Stevens, K, Offit, K, Curado, J, Tilgner, H, Guigo, R, Aiza, G, Brunet, J, Castellsague, J, Martrat, G, Urruticoechea, A, Blanco, I, Tihomirova, L, Goldgar, DE, Buys, S, John, EM, Miron, A, Southey, M, Daly, MB, Schmutzler, RK, Wappenschmidt, B, Meindl, A, Arnold, N, Deissler, H, Varon-Mateeva, R, Sutter, C, Niederacher, D, Imyamitov, E, Sinilnikova, OM, Stoppa-Lyonne, D, Mazoyer, S, Verny-Pierre, C, Castera, L, de Pauw, A, Bignon, Y-J, Uhrhammer, N, Peyrat, J-P, Vennin, P, Ferrer, SF, Collonge-Rame, M-A, Mortemousque, I, Spurdle, AB, Beesley, J, Chen, X, Healey, S, Barcellos-Hoff, MH, Vidal, M, Gruber, SB, Lazaro, C, Capella, G, McGuffog, L, Nathanson, KL, Antoniou, AC, Chenevix-Trench, G, Fleisch, MC, Moreno, V, Angel Pujana, M, Ashworth, A, Maxwell, CA, Benitez, J, Gomez-Baldo, L, Osorio, A, Bonifaci, N, Fernandez-Ramires, R, Costes, SV, Guino, E, Chen, H, Evans, GJR, Mohan, P, Catala, I, Petit, A, Aguilar, H, Villanueva, A, Aytes, A, Serra-Musach, J, Rennert, G, Lejbkowicz, F, Peterlongo, P, Manoukian, S, Peissel, B, Ripamonti, CB, Bonanni, B, Viel, A, Allavena, A, Bernard, L, Radice, P, Friedman, E, Kaufman, B, Laitman, Y, Dubrovsky, M, Milgrom, R, Jakubowska, A, Cybulski, C, Gorski, B, Jaworska, K, Durda, K, Sukiennicki, G, Lubinski, J, Shugart, YY, Domchek, SM, Letrero, R, Weber, BL, Hogervorst, FBL, Rookus, MA, Collee, JM, Devilee, P, Ligtenberg, MJ, van der Luijt, RB, Aalfs, CM, Waisfisz, Q, Wijnen, J, van Roozendaal, CEP, Easton, DF, Peock, S, Cook, M, Oliver, C, Frost, D, Harrington, P, Evans, DG, Lalloo, F, Eeles, R, Izatt, L, Chu, C, Eccles, D, Douglas, F, Brewer, C, Nevanlinna, H, Heikkinen, T, Couch, FJ, Lindor, NM, Wang, X, Godwin, AK, Caligo, MA, Lombardi, G, Loman, N, Karlsson, P, Ehrencrona, H, von Wachenfeldt, A, Barkardottir, RB, Hamann, U, Rashid, MU, Lasa, A, Caldes, T, Andres, R, Schmitt, M, Assmann, V, Stevens, K, Offit, K, Curado, J, Tilgner, H, Guigo, R, Aiza, G, Brunet, J, Castellsague, J, Martrat, G, Urruticoechea, A, Blanco, I, Tihomirova, L, Goldgar, DE, Buys, S, John, EM, Miron, A, Southey, M, Daly, MB, Schmutzler, RK, Wappenschmidt, B, Meindl, A, Arnold, N, Deissler, H, Varon-Mateeva, R, Sutter, C, Niederacher, D, Imyamitov, E, Sinilnikova, OM, Stoppa-Lyonne, D, Mazoyer, S, Verny-Pierre, C, Castera, L, de Pauw, A, Bignon, Y-J, Uhrhammer, N, Peyrat, J-P, Vennin, P, Ferrer, SF, Collonge-Rame, M-A, Mortemousque, I, Spurdle, AB, Beesley, J, Chen, X, Healey, S, Barcellos-Hoff, MH, Vidal, M, Gruber, SB, Lazaro, C, Capella, G, McGuffog, L, Nathanson, KL, Antoniou, AC, Chenevix-Trench, G, Fleisch, MC, Moreno, V, and Angel Pujana, M
- Abstract
Differentiated mammary epithelium shows apicobasal polarity, and loss of tissue organization is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of stem and progenitor cells in normal breast tissue and increased risk of developing tumors of basal-like type suggest that BRCA1 regulates stem/progenitor cell proliferation and differentiation. However, the function of BRCA1 in this process and its link to carcinogenesis remain unknown. Here we depict a molecular mechanism involving BRCA1 and RHAMM that regulates apicobasal polarity and, when perturbed, may increase risk of breast cancer. Starting from complementary genetic analyses across families and populations, we identified common genetic variation at the low-penetrance susceptibility HMMR locus (encoding for RHAMM) that modifies breast cancer risk among BRCA1, but probably not BRCA2, mutation carriers: n = 7,584, weighted hazard ratio ((w)HR) = 1.09 (95% CI 1.02-1.16), p(trend) = 0.017; and n = 3,965, (w)HR = 1.04 (95% CI 0.94-1.16), p(trend) = 0.43; respectively. Subsequently, studies of MCF10A apicobasal polarization revealed a central role for BRCA1 and RHAMM, together with AURKA and TPX2, in essential reorganization of microtubules. Mechanistically, reorganization is facilitated by BRCA1 and impaired by AURKA, which is regulated by negative feedback involving RHAMM and TPX2. Taken together, our data provide fundamental insight into apicobasal polarization through BRCA1 function, which may explain the expanded cell subsets and characteristic tumor type accompanying BRCA1 mutation, while also linking this process to sporadic breast cancer through perturbation of HMMR/RHAMM.
- Published
- 2011
27. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
- Author
-
Maxwell, CA, Benitez, J, Gomez-Baldo, L, Osorio, A, Bonifaci, N, Fernandez-Ramires, R, Costes, SV, Guino, E, Chen, H, Evans, GJR, Mohan, P, Catala, I, Petit, A, Aguilar, H, Villanueva, A, Aytes, A, Serra-Musach, J, Rennert, G, Lejbkowicz, F, Peterlongo, P, Manoukian, S, Peissel, B, Ripamonti, CB, Bonanni, B, Viel, A, Allavena, A, Bernard, L, Radice, P, Friedman, E, Kaufman, B, Laitman, Y, Dubrovsky, M, Milgrom, R, Jakubowska, A, Cybulski, C, Gorski, B, Jaworska, K, Durda, K, Sukiennicki, G, Lubinski, J, Shugart, YY, Domchek, SM, Letrero, R, Weber, BL, Hogervorst, FBL, Rookus, MA, Collee, Margriet, Devilee, P, Ligtenberg, MJ, van der Luijt, RB, Aalfs, CM, Waisfisz, Q, van Wijnen, J (Juul), Roozendaal, CEP, Easton, DF, Peock, S, Cook, M, Oliver, C, Frost, D, Harrington, P, Evans, DG, Lalloo, F, Eeles, R, Izatt, L, Chu, C, Eccles, D, Douglas, F, Brewer, C, Nevanlinna, H, Heikkinen, T, Couch, FJ, Lindor, NM, Wang, XS, Godwin, AK, Caligo, MA, Lombardi, G, Loman, N, Karlsson, P, Ehrencrona, H, von Wachenfeldt, A, Barkardottir, RB, Hamann, U, Rashid, MU, Lasa, A, Caldes, T, Andres, R, Schmitt, M, Assmann, V, Stevens, K, Offit, K, Curado, J, Tilgner, H, Guigo, R, Aiza, G, Brunet, J, Castellsague, J, Martrat, G, Urruticoechea, A, Blanco, I, Tihomirova, L, Goldgar, DE, Buys, S, John, EM, Miron, A, Southey, M, Daly, MB, Schmutzler, RK, Wappenschmidt, B, Meindl, A, Arnold, N, Deissler, H, Varon-Mateeva, R, Sutter, C, Niederacher, D, Imyamitov, E, Sinilnikova, OM, Stoppa-Lyonne, D, Mazoyer, S, Verny-Pierre, C, Castera, L, de Pauw, A, Bignon, YJ, Uhrhammer, N, Peyrat, JP, Vennin, P, Ferrer, SF, Collonge-Rame, MA, Mortemousque, I, Spurdle, AB, Beesley, J, Chen, XQ, Healey, S, Barcellos-Hoff, MH, Vidal, M, Gruber, SB, Lazaro, C (Conxi), Capella, G, McGuffog, L, Nathanson, KL, Antoniou, AC, Chenevix-Trench, G, Fleisch, MC, Moreno, V, Pujana, MA, Maxwell, CA, Benitez, J, Gomez-Baldo, L, Osorio, A, Bonifaci, N, Fernandez-Ramires, R, Costes, SV, Guino, E, Chen, H, Evans, GJR, Mohan, P, Catala, I, Petit, A, Aguilar, H, Villanueva, A, Aytes, A, Serra-Musach, J, Rennert, G, Lejbkowicz, F, Peterlongo, P, Manoukian, S, Peissel, B, Ripamonti, CB, Bonanni, B, Viel, A, Allavena, A, Bernard, L, Radice, P, Friedman, E, Kaufman, B, Laitman, Y, Dubrovsky, M, Milgrom, R, Jakubowska, A, Cybulski, C, Gorski, B, Jaworska, K, Durda, K, Sukiennicki, G, Lubinski, J, Shugart, YY, Domchek, SM, Letrero, R, Weber, BL, Hogervorst, FBL, Rookus, MA, Collee, Margriet, Devilee, P, Ligtenberg, MJ, van der Luijt, RB, Aalfs, CM, Waisfisz, Q, van Wijnen, J (Juul), Roozendaal, CEP, Easton, DF, Peock, S, Cook, M, Oliver, C, Frost, D, Harrington, P, Evans, DG, Lalloo, F, Eeles, R, Izatt, L, Chu, C, Eccles, D, Douglas, F, Brewer, C, Nevanlinna, H, Heikkinen, T, Couch, FJ, Lindor, NM, Wang, XS, Godwin, AK, Caligo, MA, Lombardi, G, Loman, N, Karlsson, P, Ehrencrona, H, von Wachenfeldt, A, Barkardottir, RB, Hamann, U, Rashid, MU, Lasa, A, Caldes, T, Andres, R, Schmitt, M, Assmann, V, Stevens, K, Offit, K, Curado, J, Tilgner, H, Guigo, R, Aiza, G, Brunet, J, Castellsague, J, Martrat, G, Urruticoechea, A, Blanco, I, Tihomirova, L, Goldgar, DE, Buys, S, John, EM, Miron, A, Southey, M, Daly, MB, Schmutzler, RK, Wappenschmidt, B, Meindl, A, Arnold, N, Deissler, H, Varon-Mateeva, R, Sutter, C, Niederacher, D, Imyamitov, E, Sinilnikova, OM, Stoppa-Lyonne, D, Mazoyer, S, Verny-Pierre, C, Castera, L, de Pauw, A, Bignon, YJ, Uhrhammer, N, Peyrat, JP, Vennin, P, Ferrer, SF, Collonge-Rame, MA, Mortemousque, I, Spurdle, AB, Beesley, J, Chen, XQ, Healey, S, Barcellos-Hoff, MH, Vidal, M, Gruber, SB, Lazaro, C (Conxi), Capella, G, McGuffog, L, Nathanson, KL, Antoniou, AC, Chenevix-Trench, G, Fleisch, MC, Moreno, V, and Pujana, MA
- Abstract
Differentiated mammary epithelium shows apicobasal polarity, and loss of tissue organization is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of stem and progenitor cells in normal breast tissue and increased risk of developing tumors of basal-like type suggest that BRCA1 regulates stem/progenitor cell proliferation and differentiation. However, the function of BRCA1 in this process and its link to carcinogenesis remain unknown. Here we depict a molecular mechanism involving BRCA1 and RHAMM that regulates apicobasal polarity and, when perturbed, may increase risk of breast cancer. Starting from complementary genetic analyses across families and populations, we identified common genetic variation at the low-penetrance susceptibility HMMR locus (encoding for RHAMM) that modifies breast cancer risk among BRCA1, but probably not BRCA2, mutation carriers: n = 7,584, weighted hazard ratio ((w)HR) = 1.09 (95% CI 1.02-1.16), p(trend) = 0.017; and n = 3,965, (w)HR = 1.04 (95% CI 0.94-1.16), p(trend) = 0.43; respectively. Subsequently, studies of MCF10A apicobasal polarization revealed a central role for BRCA1 and RHAMM, together with AURKA and TPX2, in essential reorganization of microtubules. Mechanistically, reorganization is facilitated by BRCA1 and impaired by AURKA, which is regulated by negative feedback involving RHAMM and TPX2. Taken together, our data provide fundamental insight into apicobasal polarization through BRCA1 function, which may explain the expanded cell subsets and characteristic tumor type accompanying BRCA1 mutation, while also linking this process to sporadic breast cancer through perturbation of HMMR/RHAMM.
- Published
- 2011
28. Inflammatory myofibroblastic tumour of the spinal cord: case report and review of the literature
- Author
-
Despeyroux-Ewers, M., primary, Catala�, I., additional, Collin, L., additional, Cognard, C., additional, Loubes-Lacroix, F., additional, and Manelfe, C., additional
- Published
- 2003
- Full Text
- View/download PDF
29. Oligofructose contributes to the protective role of bifidobacteria in experimental necrotising enterocolitis in quails
- Author
-
CATALA, I., primary, BUTEL, M. J., additional, BENSAADA, M., additional, POPOT, F., additional, TESSEDRE, A. C., additional, RIMBAULT, A., additional, and SZYLIT, O., additional
- Published
- 1999
- Full Text
- View/download PDF
30. Macromolecules in ordered media VIII. High-performance size-exclusion chromatography as a technique for characterizing the interaction between polyanions and cationic liposomes
- Author
-
Porcar, Iolanda, primary, Catala´, I´ngrid, additional, Garci´a, Rosa, additional, Abad, Concepcio´n, additional, and Campos, Agusti´n, additional
- Published
- 1997
- Full Text
- View/download PDF
31. Hypocholesterolemic action of beta-cyclodextrin and its effects on cholesterol metabolism in pigs fed a cholesterol-enriched diet.
- Author
-
Férézou, J, primary, Riottot, M, additional, Sérougne, C, additional, Cohen-Solal, C, additional, Catala, I, additional, Alquier, C, additional, Parquet, M, additional, Juste, C, additional, Lafont, H, additional, Mathé, D, additional, Corring, T, additional, and Lutton, C, additional
- Published
- 1997
- Full Text
- View/download PDF
32. Effects of soy proteins on plasma lipoproteins in healthy men
- Author
-
Auboiron, S., primary, Catala, I., additional, Juste, C., additional, Bornet, FRJ, additional, Corring, T., additional, and Guy-Grand, B., additional
- Published
- 1997
- Full Text
- View/download PDF
33. Use of soy proteins in cholelithiasis prevention
- Author
-
Catala, I., primary, Juste, C., additional, Benfiguig, K., additional, Ruskone-Fourmestraux, A., additional, Guy-Grand, B., additional, Bornet, F., additional, and Corring, T., additional
- Published
- 1997
- Full Text
- View/download PDF
34. Osteoclast-type giant-cell tumor of the pancreas.
- Author
-
Gil-Garcia, I, primary, Valls, C, additional, Sanchez-Marquez, A, additional, and Catala, I, additional
- Published
- 1992
- Full Text
- View/download PDF
35. Influence of caecal microflora and of two dietary protein levels on the adaptation of the exocrine pancreas: comparative study in germ-free and conventional rats.
- Author
-
Lhoste EF, Catala I, Fiszlewicz M, Gueugneau AM, Popot F, Vaissade P, Corring T, and Szylit O
- Published
- 1996
- Full Text
- View/download PDF
36. Inducing cholesterol precipitation from pig bile with -cyclodextrin and cholesterol dietary supplementation
- Author
-
Juste, C., Catala, I., Riottot, M., Andre, M., Parquet, M., Lyan, B., Beguet, F., Ferezou-Viala, J., Serougne, C., and Domingo, N.
- Published
- 1997
- Full Text
- View/download PDF
37. Mútiples pilomatrixomas asociados a enfermedad celíaca
- Author
-
Camiña Catalá, I., Lapetra Bernardos, C., Rueda García, J.A., and Aleixandre Martí, E.
- Published
- 2004
- Full Text
- View/download PDF
38. BALDUFARI general dels calendaris, testaments y altres contractes per a proves y justificacions de parenteles de Jaume Catala y de Borrull .
- Author
-
Catala i Borrull, Jaume, Notario., Anonymous, Catala i Borrull, Jaume, Notario., and Anonymous
- Abstract
admtvo.01, Tít. de la cub. : "Baldufari de molts testaments y actes annotats que importen per a algunes proves y justificacions", Tít. tomado de port., Enc. perg.
39. Radiculopathy with motor deficit: a cross-sectional study of the impact of the surgeon's experience on the indication and timing of surgical treatment.
- Author
-
Garreta-Catala I, Suarez-Perez M, Gonzalez-Cañas L, Covaro A, Videla S, Nolla JM, and Agullo-Ferre JL
- Subjects
- Humans, Cross-Sectional Studies, Spine, Surveys and Questionnaires, Radiculopathy complications, Radiculopathy surgery, Surgeons
- Abstract
Purpose: The optimal management of patients with compressive radiculopathy with motor deficit (CRMD) is controversial. Our goal was to provide evidence on the impact of the spine surgeons' experience on surgical planning and timing., Methods: Spine surgeons were invited to participate in a 5-item online survey. A literature review was carried out., Results: Of the 94 spine surgeons who responded to the survey, 70% would operate early on a patient with acute CRMD, but only 48% would do so if the radicular pain had resolved. Surgeons with more than 15 years of experience chose more conservative options. Twenty published studies were selected in the literature review., Conclusion: The optimal management of patients with compressive radiculopathy associated with a non-progressive motor loss remains unknown. The results of our survey show that surgeons with extensive surgical experience take a more conservative and cautious approach., (© 2023. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
40. Establishing a national research software award.
- Author
-
Blanc Catala I, Di Cosmo R, Giraud M, Le Berre D, Louvet V, and Renaudin S
- Abstract
Software development has become an integral part of the scholarly ecosystem, spanning all fields and disciplines. To support the sharing and creation of knowledge in line with open science principles, and particularly to enable the reproducibility of research results, it is crucial to make the source code of research software available, allowing for modification, reuse, and distribution. Recognizing the significance of open-source software contributions in academia, the second French Plan for Open Science, announced by the Minister of Higher Education and Research in 2021, introduced a National Award to promote open-source research software. This award serves multiple objectives: firstly, to highlight the software projects and teams that have devoted time and effort to develop outstanding research software, sometimes for decades, and often with little recognition; secondly, to draw attention to the importance of software as a valuable research output and to inspire new generations of researchers to follow and learn from these examples. We present here an in-depth analysis of the design and implementation of this unique initiative. As a national award established explicitly to foster Open Science practices by the French Minister of Research, it faced the intricate challenge of fairly evaluating open research software across all fields, striving for inclusivity across domains, applications, and participants. We provide a comprehensive report on the results of the first edition, which received 129 high-quality submissions. Additionally, we emphasize the impact of this initiative on the open science landscape, promoting software as a valuable research outcome, on par with publications., Competing Interests: No competing interests were disclosed., (Copyright: © 2023 Blanc Catala I et al.)
- Published
- 2023
- Full Text
- View/download PDF
41. Feasibility of a multidisciplinary group videoconferencing approach for chronic low back pain: a randomized, open-label, controlled, pilot clinical trial (EN-FORMA).
- Author
-
Garreta-Catala I, Planas-Balagué R, Abouzari R, Carnaval T, Nolla JM, Videla S, and Agulló-Ferré JL
- Subjects
- Humans, Female, Middle Aged, Male, Treatment Outcome, Feasibility Studies, Physical Therapy Modalities, Aging, Low Back Pain diagnosis, Low Back Pain therapy, Low Back Pain psychology, Chronic Pain diagnosis, Chronic Pain therapy
- Abstract
Background: Low back pain is a common condition that becomes even more prevalent with aging. A non-pharmacological multidisciplinary approach for chronic non-specific low back pain (CNSLBP) has been recommended, but integrating different healthcare professionals is challenging. A multidisciplinary group videoconferencing approach (MGVA) can be helpful. Our aim was to provide evidence on MGVA's feasibility in managing CNSLBP and its impact on clinical practice., Methods: We conducted an open-label, randomized, controlled, parallel-group pilot clinical trial with CNSLBP patients irresponsive to conservative treatment. Patients between 18 and 67 years of age were randomly assigned (1:1) to either Standard-of-Care + MGVA (experimental group) or Standard-of-Care alone (control group). MGVA consisted of integrated sessions for physical rehabilitation/physiotherapy, psychology, and social work treatments. The control group received standard clinical practice treatment. The feasibility was assessed by the number of study procedures completed to at least 80% as planned. The impact on clinical practice was evaluated by the number of patients who changed their status from "candidate" to "non-candidate" to low back surgery as the treatment of choice for CNSLBP. The SF-36, Oswestry Disability Index, and TMMS-24 questionnaires were used. We performed a whole population-based descriptive analysis., Results: We included 20 patients, but only 18 were randomized (2 withdrew consent before randomization). The mean (SD) age was 53.1 (5.9) years, and mostly women (13/18); 7 were actively employed. In the experimental group, 6/9 (67%, 95%CI:35-88%) patients attended at least 80% of the scheduled procedures, while in the control group, 8/9 (89%, 95%CI:57-98%) did. Additionally, 1 out of 4 (25%) patients in the experimental group changed their status from "candidate" for low back surgery to "non-candidate". None of the 2 patients in the control group did so. We found differences between groups in the SF-36 mental health component (p-value:0.061), Oswestry Disability Index (p-value:0.032), and TMMS-24 Repair component (p-value:0.014) at the end of the trial favoring MGVA., Conclusions: The multidisciplinary group videoconferencing approach to managing chronic non-specific low back pain was feasible, suggesting overall beneficial effects on patients' health and could play a role in changing a patient's status from "candidate" to "non-candidate" for surgery., Trial Registration: NCT05093543 (ClinicalTrials.gov), first registered in 26/10/2021., (© 2023. BioMed Central Ltd., part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
42. Detecting anal human papillomavirus infection in men who have sex with men living with HIV: implications of assay variability.
- Author
-
Torres M, Silva-Klug A, Ferrer E, Saumoy M, Trenti L, Tous S, Esteban A, Baixeras N, Catala I, Vidal A, G Bravo I, Podzamczer D, and de Sanjose S
- Subjects
- Male, Humans, Homosexuality, Male, Human Papillomavirus Viruses, Human papillomavirus 16, Human papillomavirus 18, Anal Canal, Papillomaviridae genetics, Prevalence, Papillomavirus Infections complications, Papillomavirus Infections diagnosis, Papillomavirus Infections epidemiology, Sexual and Gender Minorities, Anus Neoplasms diagnosis, Anus Neoplasms epidemiology, Anus Neoplasms pathology, HIV Infections complications, HIV Infections epidemiology
- Abstract
Background: Incidence of anal cancer (AC) caused by persistent human papillomavirus (HPV) infection has risen in the last years in men who have sex with men (MSM) living with HIV. There is consensus that this population should be screened for anal precancerous lesions, but the role of HPV DNA testing in AC screening programmes is still under debate., Objectives: This study employed two molecular test to detect anal HPV DNA and compared assay performance and prognostic value for the diagnosis of histology proven high-grade intraepithelial anal lesions., Methods: MSM living with HIV attended their regular check-up visits consisting of detection of anal HPV infection, anal cytology, digital anorectal examination and high resolution anoscopy. HPV DNA was detected using Hybrid Capture 2 High-Risk test (HC2, total assay) and LINEAR ARRAY HPV Genotyping Test (LA, type-specific assay) RESULTS: Among 274 participant, prevalence of HPV DNA was 48.5% by HC2 and 89.4% by LA. HPV16 (30.6%) and HPV6 (19.6%) were the most common genotypes identified. Prevalence of multiple HPV infections was 56.2%. Agreement between HPV DNA assays was 75.2% (κ=0.51; 95% CI 0.42 to 0.60). Total HPV detection demonstrated high sensitivity (90%; 95% CI 68.3 to 98.8) and moderate specificity (58.4%; 95% CI 50.2 to 66.3), while type-specific HPV16/18 genotyping provided an increase in specificity and showed the highest area under the curve (0.81; 95% CI 0.74 to 0.89) and Youden's index (0.63)., Conclusions: Both methodologies identified a high prevalence of anal HPV infection and multiple HPV infections in MSM living with HIV, showing a moderate overall agreement between them. Either total HPV detection or type-specific HPV16/18 detection together with a threshold ≥atypical squamous cells of undetermined significance for abnormal cytology showed an acceptable diagnostic accuracy., Competing Interests: Competing interests: Cancer Epidemiology Research Program (ST, AE, SdS and MT) has received sponsorship for grants from Merck and Co, GlaxoSmithKline, Hologic and Seegene., (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
43. Comparison of two sample collection devices for anal cytology in HIV-positive men who have sex with men: Cytology brush and Dacron swab.
- Author
-
Silva-Klug AC, Saumoy M, Baixeras N, Trenti L, Catala I, Vidal A, Torres M, Alemany L, Videla S, De San Jose S, and Podzamczer D
- Subjects
- Adult, Anus Neoplasms diagnosis, Anus Neoplasms virology, Biopsy methods, Cytodiagnosis methods, Cytological Techniques methods, HIV Infections diagnosis, HIV Seropositivity diagnosis, Homosexuality, Male, Humans, Male, Middle Aged, Papillomaviridae pathogenicity, Papillomavirus Infections diagnosis, Papillomavirus Infections pathology, Prospective Studies, Retrospective Studies, Sensitivity and Specificity, Squamous Intraepithelial Lesions diagnosis, Squamous Intraepithelial Lesions pathology, Anal Canal pathology, Anus Neoplasms pathology, HIV Infections pathology, HIV Seropositivity pathology, Specimen Handling methods
- Abstract
Objective: HIV-positive men who have sex with men (MSM) are a vulnerable group for anal cancer (AC), a cancer with a well-described precursor lesion, which can be detected early in screening programs using anal liquid-based cytology (aLBC). We aim to compare two aLBC sample collection devices: cytology brush (CB) and Dacron swab (DS)., Methods: Retrospective analysis of two consecutive study periods, the first using CB and the second DS. Participants underwent an aLBC, a human papillomavirus (HPV) DNA test and a high-resolution anoscopy (HRA), and a biopsy was performed for suspicious lesions. The sensitivity and specificity of aLBC, area under the receiver operating characteristic (ROC) curve (AUC), and concordance between cytology and HRA were assessed using Cohen's kappa coefficient., Results: A total of 239 participants were enrolled (CB group, 120; DS group, 119). aLBC was benign in 46% of samples, and high-grade squamous intraepithelial lesion (HSIL) was detected in 11.7%. Prevalence of biopsy-proven HSIL was 15.3%. No differences in cytological and histological results were observed between the groups. aLBC-HRA concordance was weak for benign results (CB group, k = 0.309; DS group, k = 0.350) as well as for HSIL (k = 0.321 and 0.387, respectively). Sensitivity and specificity were 100% and 51.4%, respectively, in the CB group and 88% and 54.3% in the DS group (AUC = 0.711 and 0.759, respectively, P-value = .514). Representation of the transformation zone (TZ) was adequate in 83.3% of samples in the CB group and 50.4% in the DS group (P-value <.001)., Conclusion: Our data suggest that both devices had similar accuracy to detect anal HSIL, although samples collected with CB are more likely to have an adequate TZ representation, the presence of which could be an indicator of sample quality., (© 2021 John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
44. Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
- Author
-
Garcia-Tejedor A, Fernandez-Gonzalez S, Ortega R, Gil-Gil M, Perez-Montero H, Fernandez-Montolí E, Stradella A, Recalde S, Soler T, Petit A, Bajen MT, Benitez A, Guma A, Campos M, Pla MJ, Martinez E, Laplana M, Pernas S, Perez-Sildekova D, Catala I, Ponce J, and Falo C
- Subjects
- Axilla, Female, Humans, Lymph Node Excision, Lymph Nodes diagnostic imaging, Lymph Nodes surgery, Neoadjuvant Therapy, Retrospective Studies, Sentinel Lymph Node Biopsy, Breast Neoplasms drug therapy, Breast Neoplasms surgery, Triple Negative Breast Neoplasms drug therapy
- Abstract
Purpose: To find a group of cN2 patients or patients with high axillary burden who become ypN0 after neoadjuvant chemotherapy (NACT) and who may benefit from avoiding a lymphadenectomy., Methods: A retrospective observational cohort study was conducted with 221 clinically staged N2 patients or patients with at least 3 suspicious lymph nodes found by ultrasound at diagnosis. The predictive factors for ypN0 analysed were age, MRI-determined tumour size, histological subtype, the Nottingham histologic grade, surrogate molecular subtype, ki-67 and vascular invasion when present. Clinical and radiological responses after NACT were also evaluated. Univariate and multivariate analyses by logistic regression were performed. Distant disease-free survival (DDFS) was calculated in relation to the status of the axillary lymph nodes after NACT., Results: After NACT, 89 patients (40.3%) had axillary pathologic complete response (pCR) (ypN0) and 132 (59.7%) had residual axillary disease (ypN+). Molecular surrogate subtype, Ki-67 expression, and the clinical and radiological responses to NACT were the only independent factors associated with ypN0. Axillary pCR was observed more often in HER2-positive and triple-negative tumours than in luminal ones (OR 7.5 and 3.6, respectively). DDFS was 88.7% (95% CI 80.7-96.7%) for ypN0 and 56.2% (95% CI 32.1-80.3%) for ypN+ (p = 0.09)., Conclusions: In HER2-positive and triple-negative breast cancer patients staged as cN2 or with high axillary burden before NACT, a sentinel lymph node biopsy after NACT could be recommended if there is a clinical and radiological response.
- Published
- 2021
- Full Text
- View/download PDF
45. Frequency, Associated Risk Factors, and Characteristics of COVID-19 Among Healthcare Personnel in a Spanish Health Department.
- Author
-
Algado-Sellés N, Gras-Valentí P, Chico-Sánchez P, Mora-Muriel JG, Soler-Molina VM, Hernández-Maldonado M, Lameiras-Azevedo AS, Jiménez-Sepúlveda NJ, Gómez-Sotero IL, Villanueva-Ruiz CO, Barrenengoa-Sañudo J, Fuster-Pérez M, Cánovas-Javega S, Cerezo-Milan P, Monerris-Palmer M, Esclapez A, Cartagena-Llopis L, García-Rivera C, Martínez-Tornero I, Nadal-Morante V, Merino-Lucas E, Rodriguez-Diaz JC, Vidal-Catala I, Llorens-Soriano P, San Inocencio D, Gil-Carbonell J, Montiel-Higuero I, Sánchez-Vela P, and Sánchez-Payá J
- Subjects
- Adult, Age Factors, Aged, COVID-19, Contact Tracing methods, Female, Humans, Male, Middle Aged, Occupations, Pandemics, Public Health Surveillance methods, Risk Factors, SARS-CoV-2, Severity of Illness Index, Sex Factors, Spain epidemiology, Tertiary Care Centers, Coronavirus Infections epidemiology, Health Personnel statistics & numerical data
- Abstract
Introduction: This study examines the frequency, associated factors, and characteristics of healthcare personnel coronavirus disease 2019 cases in a healthcare department that comprises a tertiary hospital and its associated 12 primary healthcare centers., Methods: This study included healthcare personnel that showed symptoms or were in contact with a coronavirus disease 2019 case patient from March 2, 2020 to April 19, 2020. Their evolution and characteristics (age, sex, professional category, type of contact) were recorded. Correlations between the different characteristics and risk of developing coronavirus disease 2019 and severe coronavirus disease 2019 were analyzed using chi-square tests. Their magnitudes were quantified with ORs, AORs, and their 95% CIs using a logistic regression model., Results: Of the 3,900 healthcare professionals in the department, 1,791 (45.9%) showed symptoms or were part of a contact tracing study. The prevalence of those with symptoms was 20.1% (784/3,900; 95% CI=18.8, 21.4), with coronavirus disease 2019 was 4.0% (156/3,900; 95% CI=3.4, 4.6), and with severe coronavirus disease 2019 was 0.5% (18/3,900; 95% CI=0.2, 0.7). The frequency of coronavirus disease 2019 in symptomatic healthcare personnel with a nonprotected exposure was 22.8% (112/491) and 13.7% (40/293) in those with a protected exposure (AOR=2.2, 95% CI=1.2, 3.9). The service in which the healthcare personnel performed their activity was not significantly associated with being diagnosed with coronavirus disease 2019. A total of 26.3% (10/38) of male healthcare personnel with coronavirus disease 2019 required hospitalization, compared with 6.8% (8/118) among female healthcare personnel (OR=4.9, 95% CI=1.8, 13.6)., Conclusions: A surveillance and monitoring program centred on healthcare personnel enables an understanding of the risk factors that lead to coronavirus disease 2019 among this population. This knowledge allows the refinement of the strategies for disease control and prevention in healthcare personnel during the coronavirus disease 2019 pandemic., (Copyright © 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
46. EUS cardiac puncture-guided right atrial tumor.
- Author
-
Gornals JB, de la Hera M, de Albert M, Claver E, and Catala I
- Subjects
- Aged, Fatal Outcome, Female, Heart Atria, Heart Neoplasms diagnostic imaging, Hemangiosarcoma diagnostic imaging, Humans, Endoscopic Ultrasound-Guided Fine Needle Aspiration methods, Heart Neoplasms pathology, Hemangiosarcoma pathology
- Published
- 2015
- Full Text
- View/download PDF
47. Single-session fluoroless endoscopic ultrasound-guided fine-needle aspiration and choledochoduodenostomy with a biliary lumen-apposing stent.
- Author
-
Gornals JB, Consiglieri C, Gallarreta V, Busquets J, Catala I, and Laquente B
- Subjects
- Choledochostomy instrumentation, Endoscopy, Digestive System methods, Endosonography, Female, Humans, Jaundice, Obstructive etiology, Middle Aged, Pancreatic Neoplasms complications, Pancreatic Neoplasms diagnostic imaging, Stents, Choledochostomy methods, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Jaundice, Obstructive surgery, Pancreas pathology, Pancreatic Neoplasms pathology
- Published
- 2015
- Full Text
- View/download PDF
48. Single-session endosonography and endoscopic retrograde cholangiopancreatography for biliopancreatic diseases is feasible, effective and cost beneficial.
- Author
-
Gornals JB, Moreno R, Castellote J, Loras C, Barranco R, Catala I, Xiol X, Fabregat J, and Corbella X
- Subjects
- Adult, Aged, Aged, 80 and over, Biliary Tract Diseases complications, Biopsy, Fine-Needle economics, Biopsy, Fine-Needle standards, Biopsy, Fine-Needle statistics & numerical data, Cholangiopancreatography, Endoscopic Retrograde methods, Cholangiopancreatography, Endoscopic Retrograde statistics & numerical data, Cost-Benefit Analysis, Drainage economics, Drainage methods, Endoscopic Ultrasound-Guided Fine Needle Aspiration methods, Endosonography methods, Feasibility Studies, Female, Humans, Male, Middle Aged, Pancreatic Diseases complications, Prospective Studies, Retrospective Studies, Tertiary Care Centers, Time Factors, Biliary Tract Diseases diagnosis, Cholangiopancreatography, Endoscopic Retrograde economics, Endoscopic Ultrasound-Guided Fine Needle Aspiration economics, Endosonography economics, Health Care Costs, Pancreatic Diseases diagnosis
- Abstract
Background: Endoscopic ultrasonography (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) are often required in patients with pancreaticobiliary disorders., Aims: To assess the clinical impact and costs savings of a single session EUS-ERCP., Methods: Patient and intervention data from April 2009 to March 2012 were prospectively recruited and retrospectively analyzed from a database at a tertiary hospital. Indications, diagnostic yield, procedure details, complications and costs were evaluated., Results: Fifty-five scheduled combined procedures were done in 53 patients. The accuracy of EUS-fine needle aspiration for malignancy was 90%. The main clinical indication was a malignant obstructing lesion (66%). The ERCP cannulation was successful in 67%, and in 11/15 failed ERCP (73%), drainage was completed thanks to an EUS-guided biliary drainage: 6 transmurals, 5 rendezvous. Eight patients (14%) had related complications: bacteremia (n = 3), pancreatitis (n = 2), bleeding (n = 2) and perforation (n = 1). The mean duration was 65 ± 22.2 min. The mean estimated cost for a single session was €3437, and €4095 for two separate sessions. The estimated cost savings using a single-session strategy was €658 per patient, representing a total savings of €36,189., Conclusion: Combined EUS and ERCP is safe, technically feasible and cost beneficial. Furthermore, in failed ERCP cases, the endoscopic biliary drainage can be completed with EUS-guided biliary access in the same procedure., (Copyright © 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
49. Diet, length of gestation, and fecal short chain fatty acids in healthy premature neonates.
- Author
-
Favre A, Szylit O, Popot F, Catala I, Rondeau C, Maurage C, Gold F, Borderon JC, and Butel MJ
- Subjects
- Age Factors, Aging metabolism, Chromatography, Gas, Colon metabolism, Diet, Digestive System Diseases diagnosis, Fermentation, Gestational Age, Humans, Hydrogen-Ion Concentration, Infant Nutritional Physiological Phenomena, Infant, Newborn, Infant, Premature, Diseases diagnosis, Lactase, Lactose administration & dosage, Lactose metabolism, beta-Galactosidase metabolism, Fatty Acids, Volatile analysis, Feces chemistry, Infant Food, Infant, Premature metabolism, Milk, Human metabolism
- Abstract
Background: Excretion of fecal short-chain fatty acids (SCFAs) may indicate changes in colonic or colonocyte metabolism. The aim of this study was to detect the influence of gestational age and feeding practices on SCFA concentrations and profiles in healthy preterm infants., Methods: A total of 198 fecal samples (28 infants) were collected from 8 to 21 days of age from 3 groups of preterm infants born at 33 to 37 weeks of gestation and fed either breast milk (group I) or Nutramigen, a lactose-free formula (group II), and extremely preterm infants born before 33 weeks of gestation and fed breast milk (group III). Total SCFA concentrations and SCFA profiles were analyzed using a gas chromographic (GC) procedure., Results: Total fecal SCFA excretion did not differ significantly between group I (mean, 24.0 micromol/g; range, 1.3 to 118.8 micromol/g) and group II (mean, 23.0 micromol/g; range, 3.0 to 73.3 micromol/g). Conversely, differences occurred between SCFA profiles and became significant after day 17. The main differences were a significant increase in the butyric acid concentration (12% versus 30%) with group II. Compared with group I, fecal SCFA concentrations were 3.2-fold lower (7.4 micromol/g; range, 0.3 to 37.4 micromol/g) in group III with no significant changes in the profiles., Conclusions: Fecal SCFA excretion may vary in absence of any digestive disease. During this study, in terms of gestational age, total SCFA concentrations were significantly lower in extremely premature infants compared with infants born less premature, despite their known higher deficiency in intestinal lactase activity. In terms of diet, the absence of lactose did not lead to a decrease in colonic fermentation and induced changes in SCFA patterns. These new baseline data may offer clues to further development of milk formulas.
- Published
- 2002
- Full Text
- View/download PDF
50. Cholesterol crystallization in gall-bladder bile of pigs given cholesterol-beta-cyclodextrin-enriched diets with either casein or soyabean concentrate as protein sources.
- Author
-
Catala I, Juste C, Boehler N, Férézou J, André M, Riottot M, Lutton C, Lafont H, Bornet F, and Corring T
- Subjects
- Animals, Bile metabolism, Caseins administration & dosage, Cholesterol administration & dosage, Crystallization, Cyclodextrins adverse effects, Male, Soybean Proteins administration & dosage, Swine, Bile chemistry, Cholesterol chemistry, Cyclodextrins administration & dosage, Dietary Proteins metabolism, Soybean Proteins metabolism
- Abstract
Cholesterol precipitation from supersaturated bile is the earliest and determinant step in the formation of cholesterol gallstones, which is thought to be diet-dependent. Bile composition, appearance and growth of cholesterol crystals were studied in fresh gall-bladder biles from pigs adapted to four different protein-containing diets over 3 weeks: 160 g dietary protein/kg as casein (C16; n 6), or as soyabean-protein concentrate (S16; n 6), or a mixture of both protein sources (casein-soyabean protein, 70:30, w/w) (CS16; n 6), or 320 g of the mixed protein/kg (CS32; n 6). Moreover, all four diets contained 3 g cholesterol/kg and 50 g beta-cyclodextrin/kg as modifiers of bile composition towards cholesterol pro-crystallization. Cholesterol precipitation was most active after the high-protein diet, CS32, and the casein diet, C16, and lowest after the soyabean-protein diet, S16. It was intermediate after the mixed diet, CS16, but still much lower than in the former two groups. These diet-induced variations were suggested to be mediated through modifications in the biliary profile of bile acids, whereas all other biliary constituents studied were essentially unchanged. The fasting level of plasma cholesterol was lowest in both 160 g protein/kg diets containing soyabean protein (S16 and CS16), highest for the high-protein diet CS32, and intermediate for the C16 diet. These results should encourage clinical studies on the effect of soyabean protein, or other vegetable proteins, for primary or recurrence prevention of cholelithiasis at its earliest stage.
- Published
- 2000
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.